Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1006 AL 1020

[Fall risk and fracture. Falls in patients with dementia]

Komatsu T.

Clin Calcium. 2013 May;23(5):731-8.

The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: a meta-analysis

Yuan Y, Tong Q, Zhou X, Zhang R, Qi Z, Zhang K.

Gene. 2013 Jul 25;524(2):133-8. doi: 10.1016/j.gene.2013.04.045. Epub 2013 Apr 26.

Tremor of the eyes, or of the head, in Parkinson's disease?

Leigh RJ, Martinez-Conde S.

Mov Disord. 2013 Jun;28(6):691-3. doi: 10.1002/mds.25478. Epub 2013 Apr 29.

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F; Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators.

Mov Disord. 2013 Jul;28(8):1064-71. doi: 10.1002/mds.25364. Epub 2013 Apr 29.

Effect of expectancy and personality on cortical excitability in Parkinson's disease

Lou JS, Dimitrova DM, Hammerschlag R, Nutt J, Hunt EA, Eaton RW, Johnson SC, Davis MD, Arnold GC, Andrea SB, Oken BS.

Mov Disord. 2013 Aug;28(9):1257-62. doi: 10.1002/mds.25471. Epub 2013 Apr 29.

Anesthetic management in a patient with Wolff-Parkinson-White syndrome for laparoscopic cholecystectomy

Gupta A, Sharma J, Banerjee N, Sood R.

Anesth Essays Res. 2013 May-Aug;7(2):270-2. doi: 10.4103/0259-1162.118988.

[Smoking and neurological disorders]

Fujii H, Hosomi N, Matsumoto M.

Nihon Rinsho. 2013 Mar;71(3):423-9.

Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia

Silver M, Factor SA.

Parkinsonism Relat Disord. 2013 Aug;19(8):758-60. doi: 10.1016/j.parkreldis.2013.03.016. Epub 2013 Apr 28.

Physical activity behavior change in persons with neurologic disorders: overview and examples from Parkinson disease and multiple sclerosis

Ellis T, Motl RW.

J Neurol Phys Ther. 2013 Jun;37(2):85-90. doi: 10.1097/NPT.0b013e31829157c0.

Aerobic exercise to improve executive function in Parkinson disease: a case series

Tabak R, Aquije G, Fisher BE.

J Neurol Phys Ther. 2013 Jun;37(2):58-64. doi: 10.1097/NPT.0b013e31829219bc.

Infectious particles, stress, and induced prion amyloids: a unifying perspective

Manuelidis L.

Virulence. 2013 Jul 1;4(5):373-83. doi: 10.4161/viru.24838. Epub 2013 Apr 30.

N-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-4-[(11)C]methoxy-N-methylbenzamide

Leung K.

2013 Feb 14 [updated 2013 May 2]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

N-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-N-methyl-4-[(11)C]methylbenzamide

Leung K.

2013 Feb 19 [updated 2013 May 2]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Rasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease

Solís-García del Pozo J, Mínguez-Mínguez S, de Groot PW, Jordán J.

Expert Opin Drug Saf. 2013 Jul;12(4):479-86. doi: 10.1517/14740338.2013.790956. Epub 2013 May 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias